Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Frequent mutation of BAP1 in metastasizing uveal melanomas.

Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM.

Science. 2010 Dec 3;330(6009):1410-3. doi: 10.1126/science.1194472. Epub 2010 Nov 4.

2.

Tumours associated with BAP1 mutations.

Murali R, Wiesner T, Scolyer RA.

Pathology. 2013 Feb;45(2):116-26. doi: 10.1097/PAT.0b013e32835d0efb. Review.

PMID:
23277170
3.

Genetics of primary intraocular tumors.

Nagarkatti-Gude N, Wang Y, Ali MJ, Honavar SG, Jager MJ, Chan CC.

Ocul Immunol Inflamm. 2012 Aug;20(4):244-54. doi: 10.3109/09273948.2012.702843. Review.

4.

Gene of the month: BAP1.

Wang A, Papneja A, Hyrcza M, Al-Habeeb A, Ghazarian D.

J Clin Pathol. 2016 Sep;69(9):750-3. doi: 10.1136/jclinpath-2016-203866. Epub 2016 May 27. Review.

PMID:
27235536
5.

Genomic, prognostic, and cell-signaling advances in uveal melanoma.

Harbour JW.

Am Soc Clin Oncol Educ Book. 2013:388-91. doi: 10.1200/EdBook_AM.2013.33.388. Review.

6.

New concepts in the molecular understanding of uveal melanoma.

Reichstein D.

Curr Opin Ophthalmol. 2017 May;28(3):219-227. doi: 10.1097/ICU.0000000000000366. Review.

PMID:
28257297
7.

Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.

Cheung M, Talarchek J, Schindeler K, Saraiva E, Penney LS, Ludman M, Testa JR.

Cancer Genet. 2013 May;206(5):206-10. doi: 10.1016/j.cancergen.2013.05.018. Review.

PMID:
23849051
8.

Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.

Martorano LM, Winkelmann RR, Cebulla CM, Abdel-Rahman MH, Campbell SM.

Int J Dermatol. 2014 Jun;53(6):657-63. doi: 10.1111/ijd.12386. Epub 2014 Apr 2. Review.

PMID:
24697775
9.

BAP1 and cancer.

Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G.

Nat Rev Cancer. 2013 Mar;13(3):153-9. doi: 10.1038/nrc3459. Review.

10.

Recent developments in prognostic and predictive testing in uveal melanoma.

Field MG, Harbour JW.

Curr Opin Ophthalmol. 2014 May;25(3):234-9. doi: 10.1097/ICU.0000000000000051. Review.

11.

Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.

Fukuda T, Tsuruga T, Kuroda T, Nishikawa H, Ohta T.

Curr Cancer Drug Targets. 2016;16(2):101-9. Review.

PMID:
26517537
12.

[Uveal melanoma: current insights into clinical relevance of genetic testing].

Metz CH, Lohmann D, Zeschnigk M, Bornfeld N.

Klin Monbl Augenheilkd. 2013 Jul;230(7):686-91. doi: 10.1055/s-0033-1350628. Epub 2013 Jul 22. Review. German.

PMID:
23877823
13.

Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.

Rai K, Pilarski R, Cebulla CM, Abdel-Rahman MH.

Clin Genet. 2016 Mar;89(3):285-94. doi: 10.1111/cge.12630. Epub 2015 Jul 14. Review.

14.

Connecting molecular pathways to hereditary cancer risk syndromes.

Testa JR, Malkin D, Schiffman JD.

Am Soc Clin Oncol Educ Book. 2013:81-90. doi: 10.1200/EdBook_AM.2013.33.81. Review.

15.

The genetics of uveal melanoma: an emerging framework for targeted therapy.

Harbour JW.

Pigment Cell Melanoma Res. 2012 Mar;25(2):171-81. doi: 10.1111/j.1755-148X.2012.00979.x. Epub 2012 Feb 13. Review.

16.

A review of advanced genetic testing for clinical prognostication in uveal melanoma.

Werdich XQ, Jakobiec FA, Singh AD, Kim IK.

Semin Ophthalmol. 2013 Sep-Nov;28(5-6):361-71. doi: 10.3109/08820538.2013.825290. Epub 2013 Sep 6. Review.

PMID:
24010756

Supplemental Content

Support Center